dr. jacobson on the safety profile of axi-cel in relapsed/refractory indolent lymphoma
Published 4 years ago • 64 plays • Length 1:22Download video MP4
Download video MP3
Similar videos
-
0:57
dr. jacobson on the benefit of axi-cel in relapsed/refractory follicular lymphoma
-
1:49
dr. jacobson on design of zuma-5 trial in r/r indolent non-hodgkin lymphoma
-
6:03
clinical data for axi-cel in lymphoma
-
1:09
dr. neelapu discusses efficacy of axi-cel in large b-cell lymphoma
-
4:51
zuma-5: axi-cel for r/r non-hodgkin lymphoma
-
7:30
treating relapsed/refractory mantle cell lymphoma
-
6:18
treatment of follicular lymphoma
-
1:15
primary overall survival analysis of the zuma-7 trial
-
3:53
standard-of-care setting results of axi-cel in r/r large b-cell lymphoma
-
1:16
dr. brody on addressing resistance to immunotherapy in non-hodgkin lymphoma
-
1:33
dr. john leonard on treatment options for relapsed follicular lymphoma
-
19:05
update: relapsed/refractory follicular lymphoma
-
1:53
latest updates in car-t therapy for follicular lymphoma
-
10:21
advances in car-t therapy for lymphoma
-
2:06:26
new and emerging therapies for follicular lymphoma
-
6:20
frontline treatment for follicular lymphoma
-
2:00
dr. nastoupil on pembrolizumab plus rituximab in relapsed follicular lymphoma
-
1:18
dr. abramson discusses transcend in relapsed/refractory b-cell lymphomas
-
7:19
expanding the role of car t in non-hodgkin lymphoma